Yash Agarwal - Concepedia

Author

Yash Agarwal

Massachusetts Institute of Technology ORCID

Also Known As

Yash Agarwal

Publications

722

Citations

H-Index

Concepts

All Affiliations

Massachusetts Institute of Technology Ragon Institute of MGH, MIT and Harvard Scripps Research Institute Howard Hughes Medical Institute Harvard–MIT Division of Health Sciences and Technology

About

Yash Agarwal is an author at Massachusetts Institute of Technology specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	473
2	Immunology	4	4	473
3	Cell Biology	2	2	88
4	Autoimmunity	2	2	316
5	Autoimmune Disease	1	1	258

Yash Agarwal

Publications

702

Citations

H-Index

Page 1

	Year	Citations
Engineered immunogen binding to alum adjuvant enhances humoral immunity Tyson J. Moyer, Yu Kato, Wuhbet Abraham, Nature Medicine Autoimmune DiseaseHumoral ResponseImmunologyAutoimmunityHumoral Immunity	2020	258
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity Yash Agarwal, Lauren E. Milling, Jason Y.H. Chang, Nature Biomedical Engineering InflammationCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2022	127
High-performance chemical- and light-inducible recombinases in mammalian cells and mice Benjamin H. Weinberg, Jang Hwan Cho, Yash Agarwal, Nature Communications	2019	70
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains Khloe S. Gordon, Taeyoon Kyung, Caleb R. Perez, Nature Biomedical Engineering MedicineImmunologyImmunologic MechanismAntigen ProcessingAutoimmunity	2022	58
NAPS update: network analysis of molecular dynamics data and protein–nucleic acid complexes Broto Chakrabarty, Varun Naganathan, Kanak Garg, Nucleic Acids Research	2019	57
Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade Chensu Wang, Ang Cui, Maurice Bukenya, Cell Reports	2021	36
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies Emi A. Lutz, Yash Agarwal, Noor Momin, Proceedings of the National Academy of Sciences ImmunoeditingImmunologyImmune RegulationAntitumor EfficacyIfnβ Therapies	2022	30
Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation Lauren E. Milling, Daniel Garafola, Yash Agarwal, Cancer Immunology Research	2021	29
Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation. Lauren E. Milling, Daniel Garafola, Yash Agarwal, PubMed	2022	17
Tumor-localized catalases can fail to alter tumor growth and transcriptional profiles in subcutaneous syngeneic mouse tumor models Allison Sheen, Yash Agarwal, Keith M. Cheah, Redox Biology	2023	10

Page 1